✦ LIBER ✦

Predictors of Cancer Worry in Unaffected Women from High Risk Breast Cancer Families: Risk Perception is not the Primary Issue

✍ Scribed by Melanie Anne Price; Phyllis Noami Butow; Sing Kai Lo; Judy Wilson; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab) Psychosocial Group

Publisher: Springer
Year: 2007
Tongue: English
Weight: 193 KB
Volume: 16
Category: Article
ISSN: 1059-7700
DOI: 10.1007/s10897-007-9105-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of a Communication Aid to Fa

Development of a Communication Aid to Facilitate Risk Communication in Consultations with Unaffected Women from High Risk Breast Cancer Families: A Pilot Study

✍ E. A. Lobb; P. N. Butow; A. Moore; A. Barratt; K. Tucker; C. Gaff; J. Kirk; T. D 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 591 KB

Factors implicated in the decision wheth

Factors implicated in the decision whether or not to join the tamoxifen trial in women at high familial risk of breast cancer

✍ E. Lovegrove; N. Rumsey; D. Harcourt; S.J. Cawthorn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

Why, given similar medical circumstances-high familial risk of breast cancer -will some women elect to join a trial of drugs designed to reduce that risk but others choose not to take part? The aim of this study was to identify measurable differences between women who elect to join a placebo-control

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen